Tanvex BioPharma Competitors and Similar CompaniesClear all
Tanvex BioPharma's competitors and similar companies include OBI Pharma, PharmaEssentia, Bora Pharmaceuticals and Lotus Pharmaceutical.
 Tanvex BioPharma Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs. |  PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. |  Bora Pharmaceuticals Bora Pharmaceuticals is a company that develops, manufactures, and sells branded, generic, and over the counter (OTC) healthcare products. |  Lotus Pharmaceutical Lotus Pharmaceutical (美時化學製藥股份有限公司) is a company that develops, manufactures, and markets pharmaceutical products. | ||
Founding Date | Founding Date 2013 | Founding Date 2002 | Founding Date 2003 | Founding Date 2007 | Founding Date 1966 |
Type | Type Public | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Taipei, TW HQ New Taipei, TW Irvine, US San Diego, US San Diego, US | Locations TW HQ San Diego, US | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US | Locations TW HQ Wilmington, US | Locations Taipei City, TW HQ Singapore, SG Ho Chi Minh City, VN |
Employees | Employees 13827% decrease | Employees 124 | Employees 4897% increase | Employees 6553% increase | Employees 66911% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) NT$401m (FY, 2025) | Revenue (est.) NT$62.7m (FY, 2024) | Revenue (est.) NT$15.6b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) NT$20.5b (FY, 2025) |
Cost of goods | Cost of goods NT$466.3m (FY, 2025) | Cost of goods NT$139m (FY, 2024) | Cost of goods NT$1.3b (FY, 2025) | Cost of goods N/A | Cost of goods NT$7b (FY, 2025) |
Gross profit | Gross profit (NT$10.6m) (FY, 2025) | Gross profit (NT$63.2m) (FY, 2024) | Gross profit NT$14.4b (FY, 2025) | Gross profit N/A | Gross profit NT$13.6b (FY, 2025) |
Net income | Net income (NT$1.5b) (FY, 2025) | Net income (NT$2.5b) (FY, 2024) | Net income NT$5b (FY, 2025) | Net income N/A | Net income NT$4.7b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
OBI Pharma
HQ
TW
Employees
124
OBI Pharma (台灣浩鼎) is a bio-pharma company focused on cancer therapeutics.
View companyPharmaEssentia
HQ
Taipei, TW
Employees
489↑ 7% increase
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View companyBora Pharmaceuticals
HQ
TW
Employees
655↑ 3% increase
Bora Pharmaceuticals is a company that develops, manufactures, and sells branded, generic, and over the counter (OTC) healthcare products.
View companyLotus Pharmaceutical
HQ
Taipei City, TW
Employees
669↑ 11% increase
Lotus Pharmaceutical (美時化學製藥股份有限公司) is a company that develops, manufactures, and markets pharmaceutical products.
View company